NOVASSAY SA has a total of 26 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2013. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are CEPHALON FRANCE, FRENKEL ANTON and BIOELECTRON TECH CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Brazil | 2 | |
#8 | Russian Federation | 1 | |
#9 | United States | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Meghani Premji | 14 |
#2 | Kricek Franz | 13 |
#3 | Ford Rhonan Lee | 7 |
#4 | Skouteris George | 6 |
#5 | Premji Meghani | 2 |
#6 | Marc Kearsey Jonathan | 2 |
#7 | Rhonan Lee Ford | 2 |
#8 | George Skouteris | 1 |
#9 | Kearsey Marc Jonathan | 1 |
#10 | Franz Kricek | 1 |
Publication | Filing date | Title |
---|---|---|
CN110945014A | Voltage-gated calcium channel defect subunit α 2 delta and application thereof | |
AU2016232606A1 | Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one | |
AU2014364693A1 | Gamma-aminobutyric acid (GABA) analogues for the treatment of pain and other disorders | |
WO2014029756A1 | Cholyl-l-lysyl-fluorescein assay |